Which has stronger valuation & earnings, ELV or CNC?

Elevance Health has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Elevance Health $199.13B 0.44 $5.66B $23.51 17.17 Centene $194.78B 0.17 -$6.67B -$13.14 N/A

Does the media refer more to ELV or CNC?

In the previous week, Elevance Health had 8 more articles in the media than Centene. MarketBeat recorded 21 mentions for Elevance Health and 13 mentions for Centene. Elevance Health's average media sentiment score of 1.07 beat Centene's score of 0.50 indicating that Elevance Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elevance Health 17 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Centene 4 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor ELV or MOH?

In the previous week, Elevance Health had 2 more articles in the media than Molina Healthcare. MarketBeat recorded 21 mentions for Elevance Health and 19 mentions for Molina Healthcare. Molina Healthcare's average media sentiment score of 1.25 beat Elevance Health's score of 1.07 indicating that Molina Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elevance Health 17 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Molina Healthcare 15 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor ELV or UNH?

In the previous week, UnitedHealth Group had 75 more articles in the media than Elevance Health. MarketBeat recorded 96 mentions for UnitedHealth Group and 21 mentions for Elevance Health. UnitedHealth Group's average media sentiment score of 1.24 beat Elevance Health's score of 1.07 indicating that UnitedHealth Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elevance Health 17 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive UnitedHealth Group 73 Very Positive mention(s) 5 Positive mention(s) 7 Neutral mention(s) 4 Negative mention(s) 3 Very Negative mention(s) Positive

Which has better valuation & earnings, ELV or CI?

Cigna Group has higher revenue and earnings than Elevance Health. Cigna Group is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Elevance Health $199.13B 0.44 $5.66B $23.51 17.17 Cigna Group $274.90B 0.29 $5.96B $23.59 12.62

Does the media prefer ELV or CI?

In the previous week, Cigna Group had 8 more articles in the media than Elevance Health. MarketBeat recorded 29 mentions for Cigna Group and 21 mentions for Elevance Health. Cigna Group's average media sentiment score of 1.46 beat Elevance Health's score of 1.07 indicating that Cigna Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elevance Health 17 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cigna Group 27 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, HUM or ELV?

Elevance Health has higher revenue and earnings than Humana. Elevance Health is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Humana $129.66B 0.35 $1.19B $9.35 40.58 Elevance Health $199.13B 0.44 $5.66B $23.51 17.17

Is HUM or ELV more profitable?

Elevance Health has a net margin of 2.62% compared to Humana's net margin of 0.82%. Elevance Health's return on equity of 15.58% beat Humana's return on equity. Company Net Margins Return on Equity Return on Assets Humana 0.82% 10.45% 3.75% Elevance Health 2.62% 15.58% 5.57%

Does the media favor HUM or ELV?

In the previous week, Elevance Health had 3 more articles in the media than Humana. MarketBeat recorded 21 mentions for Elevance Health and 18 mentions for Humana. Elevance Health's average media sentiment score of 1.07 beat Humana's score of 0.61 indicating that Elevance Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Humana 5 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Elevance Health 17 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Elevance Health (ELV) Competitors

$403.74 +4.56 (+1.14%)

Closing price 06/12/2026 03:59 PM Eastern

Extended Trading

$401.50 -2.24 (-0.55%)

As of 06/12/2026 07:28 PM Eastern

Compare

ELV vs. CNC, MOH, UNH, CI, and HUM

Should you buy Elevance Health stock or one of its competitors? MarketBeat compares Elevance Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Elevance Health include Centene (CNC), Molina Healthcare (MOH), UnitedHealth Group (UNH), Cigna Group (CI), and Humana (HUM). These companies are all part of the "managed health care" industry.

How does Elevance Health compare to Centene?

Elevance Health (NYSE:ELV) and Centene (NYSE:CNC) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, profitability, dividends and analyst recommendations.

Elevance Health has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elevance Health	$199.13B	0.44	$5.66B	$23.51	17.17
Centene	$194.78B	0.17	-$6.67B	-$13.14	N/A

Elevance Health has a net margin of 2.62% compared to Centene's net margin of -3.25%. Elevance Health's return on equity of 15.58% beat Centene's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elevance Health	2.62%	15.58%	5.57%
Centene	-3.25%	5.57%	1.54%

Elevance Health presently has a consensus price target of $416.11, indicating a potential upside of 3.06%. Centene has a consensus price target of $60.24, indicating a potential downside of 7.58%. Given Elevance Health's stronger consensus rating and higher possible upside, equities research analysts plainly believe Elevance Health is more favorable than Centene.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elevance Health	0 Sell rating(s)	9 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.61
Centene	2 Sell rating(s)	9 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.37

89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 93.6% of Centene shares are owned by institutional investors. 0.3% of Elevance Health shares are owned by company insiders. Comparatively, 0.4% of Centene shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Elevance Health has a beta of 0.67, meaning that its share price is 33% less volatile than the broader market. Comparatively, Centene has a beta of 1.09, meaning that its share price is 9% more volatile than the broader market.

In the previous week, Elevance Health had 8 more articles in the media than Centene. MarketBeat recorded 21 mentions for Elevance Health and 13 mentions for Centene. Elevance Health's average media sentiment score of 1.07 beat Centene's score of 0.50 indicating that Elevance Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elevance Health	17 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Centene	4 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Elevance Health beats Centene on 13 of the 17 factors compared between the two stocks.

How does Elevance Health compare to Molina Healthcare?

Elevance Health (NYSE:ELV) and Molina Healthcare (NYSE:MOH) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership, media sentiment and dividends.

In the previous week, Elevance Health had 2 more articles in the media than Molina Healthcare. MarketBeat recorded 21 mentions for Elevance Health and 19 mentions for Molina Healthcare. Molina Healthcare's average media sentiment score of 1.25 beat Elevance Health's score of 1.07 indicating that Molina Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elevance Health	17 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Molina Healthcare	15 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

89.2% of Elevance Health shares are held by institutional investors. Comparatively, 98.5% of Molina Healthcare shares are held by institutional investors. 0.3% of Elevance Health shares are held by insiders. Comparatively, 1.4% of Molina Healthcare shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Elevance Health has higher revenue and earnings than Molina Healthcare. Elevance Health is trading at a lower price-to-earnings ratio than Molina Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elevance Health	$199.13B	0.44	$5.66B	$23.51	17.17
Molina Healthcare	$45.43B	0.23	$472M	$3.38	59.33

Elevance Health has a net margin of 2.62% compared to Molina Healthcare's net margin of 0.42%. Elevance Health's return on equity of 15.58% beat Molina Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elevance Health	2.62%	15.58%	5.57%
Molina Healthcare	0.42%	8.76%	2.32%

Elevance Health has a beta of 0.67, suggesting that its stock price is 33% less volatile than the broader market. Comparatively, Molina Healthcare has a beta of 0.8, suggesting that its stock price is 20% less volatile than the broader market.

Elevance Health currently has a consensus price target of $416.11, indicating a potential upside of 3.06%. Molina Healthcare has a consensus price target of $182.73, indicating a potential downside of 8.88%. Given Elevance Health's stronger consensus rating and higher probable upside, equities research analysts plainly believe Elevance Health is more favorable than Molina Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elevance Health	0 Sell rating(s)	9 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.61
Molina Healthcare	2 Sell rating(s)	11 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.06

Summary

Elevance Health beats Molina Healthcare on 11 of the 16 factors compared between the two stocks.

How does Elevance Health compare to UnitedHealth Group?

Elevance Health (NYSE:ELV) and UnitedHealth Group (NYSE:UNH) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends, media sentiment and earnings.

UnitedHealth Group has a net margin of 2.68% compared to Elevance Health's net margin of 2.62%. Elevance Health's return on equity of 15.58% beat UnitedHealth Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elevance Health	2.62%	15.58%	5.57%
UnitedHealth Group	2.68%	14.65%	4.77%

Elevance Health has a beta of 0.67, indicating that its share price is 33% less volatile than the broader market. Comparatively, UnitedHealth Group has a beta of 0.64, indicating that its share price is 36% less volatile than the broader market.

89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 87.9% of UnitedHealth Group shares are owned by institutional investors. 0.3% of Elevance Health shares are owned by company insiders. Comparatively, 0.3% of UnitedHealth Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Elevance Health currently has a consensus price target of $416.11, suggesting a potential upside of 3.06%. UnitedHealth Group has a consensus price target of $407.17, suggesting a potential downside of 0.29%. Given Elevance Health's higher probable upside, equities research analysts plainly believe Elevance Health is more favorable than UnitedHealth Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elevance Health	0 Sell rating(s)	9 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.61
UnitedHealth Group	1 Sell rating(s)	5 Hold rating(s)	20 Buy rating(s)	1 Strong Buy rating(s)	2.78

Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.7%. UnitedHealth Group pays an annual dividend of $8.84 per share and has a dividend yield of 2.2%. Elevance Health pays out 29.3% of its earnings in the form of a dividend. UnitedHealth Group pays out 66.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has raised its dividend for 14 consecutive years and UnitedHealth Group has raised its dividend for 15 consecutive years. UnitedHealth Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

UnitedHealth Group has higher revenue and earnings than Elevance Health. Elevance Health is trading at a lower price-to-earnings ratio than UnitedHealth Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elevance Health	$199.13B	0.44	$5.66B	$23.51	17.17
UnitedHealth Group	$447.57B	0.83	$12.06B	$13.24	30.84

In the previous week, UnitedHealth Group had 75 more articles in the media than Elevance Health. MarketBeat recorded 96 mentions for UnitedHealth Group and 21 mentions for Elevance Health. UnitedHealth Group's average media sentiment score of 1.24 beat Elevance Health's score of 1.07 indicating that UnitedHealth Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elevance Health	17 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
UnitedHealth Group	73 Very Positive mention(s)	5 Positive mention(s)	7 Neutral mention(s)	4 Negative mention(s)	3 Very Negative mention(s)	Positive

Summary

UnitedHealth Group beats Elevance Health on 12 of the 20 factors compared between the two stocks.

How does Elevance Health compare to Cigna Group?

Elevance Health (NYSE:ELV) and Cigna Group (NYSE:CI) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, earnings, dividends, analyst recommendations, institutional ownership and valuation.

Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.7%. Cigna Group pays an annual dividend of $6.24 per share and has a dividend yield of 2.1%. Elevance Health pays out 29.3% of its earnings in the form of a dividend. Cigna Group pays out 26.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has raised its dividend for 14 consecutive years and Cigna Group has raised its dividend for 5 consecutive years. Cigna Group is clearly the better dividend stock, given its higher yield and lower payout ratio.

Cigna Group has higher revenue and earnings than Elevance Health. Cigna Group is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elevance Health	$199.13B	0.44	$5.66B	$23.51	17.17
Cigna Group	$274.90B	0.29	$5.96B	$23.59	12.62

In the previous week, Cigna Group had 8 more articles in the media than Elevance Health. MarketBeat recorded 29 mentions for Cigna Group and 21 mentions for Elevance Health. Cigna Group's average media sentiment score of 1.46 beat Elevance Health's score of 1.07 indicating that Cigna Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elevance Health	17 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cigna Group	27 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Elevance Health has a net margin of 2.62% compared to Cigna Group's net margin of 2.26%. Cigna Group's return on equity of 19.75% beat Elevance Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elevance Health	2.62%	15.58%	5.57%
Cigna Group	2.26%	19.75%	5.30%

Elevance Health has a beta of 0.67, meaning that its share price is 33% less volatile than the broader market. Comparatively, Cigna Group has a beta of 0.28, meaning that its share price is 72% less volatile than the broader market.

Elevance Health currently has a consensus target price of $416.11, indicating a potential upside of 3.06%. Cigna Group has a consensus target price of $338.80, indicating a potential upside of 13.78%. Given Cigna Group's stronger consensus rating and higher probable upside, analysts clearly believe Cigna Group is more favorable than Elevance Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elevance Health	0 Sell rating(s)	9 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.61
Cigna Group	0 Sell rating(s)	6 Hold rating(s)	15 Buy rating(s)	1 Strong Buy rating(s)	2.77

89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 87.0% of Cigna Group shares are owned by institutional investors. 0.3% of Elevance Health shares are owned by company insiders. Comparatively, 0.6% of Cigna Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Cigna Group beats Elevance Health on 13 of the 20 factors compared between the two stocks.

How does Elevance Health compare to Humana?

Humana (NYSE:HUM) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings, profitability and media sentiment.

Humana has a beta of 0.76, meaning that its stock price is 24% less volatile than the broader market. Comparatively, Elevance Health has a beta of 0.67, meaning that its stock price is 33% less volatile than the broader market.

In the previous week, Elevance Health had 3 more articles in the media than Humana. MarketBeat recorded 21 mentions for Elevance Health and 18 mentions for Humana. Elevance Health's average media sentiment score of 1.07 beat Humana's score of 0.61 indicating that Elevance Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Humana	5 Very Positive mention(s)	1 Positive mention(s)	8 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Elevance Health	17 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

92.4% of Humana shares are held by institutional investors. Comparatively, 89.2% of Elevance Health shares are held by institutional investors. 0.2% of Humana shares are held by insiders. Comparatively, 0.3% of Elevance Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Elevance Health has a net margin of 2.62% compared to Humana's net margin of 0.82%. Elevance Health's return on equity of 15.58% beat Humana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Humana	0.82%	10.45%	3.75%
Elevance Health	2.62%	15.58%	5.57%

Humana pays an annual dividend of $3.54 per share and has a dividend yield of 0.9%. Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.7%. Humana pays out 37.9% of its earnings in the form of a dividend. Elevance Health pays out 29.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has raised its dividend for 14 consecutive years. Elevance Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Humana currently has a consensus target price of $291.35, suggesting a potential downside of 23.21%. Elevance Health has a consensus target price of $416.11, suggesting a potential upside of 3.06%. Given Elevance Health's stronger consensus rating and higher probable upside, analysts clearly believe Elevance Health is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Humana	4 Sell rating(s)	15 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.21
Elevance Health	0 Sell rating(s)	9 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.61

Elevance Health has higher revenue and earnings than Humana. Elevance Health is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Humana	$129.66B	0.35	$1.19B	$9.35	40.58
Elevance Health	$199.13B	0.44	$5.66B	$23.51	17.17

Summary

Elevance Health beats Humana on 16 of the 20 factors compared between the two stocks.

Get Elevance Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ELV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ELV vs. The Competition

Export

Metric	Elevance Health	Medical Services Industry	Medical Sector	NYSE Exchange
Market Cap	$87.75B	$8.91B	$6.74B	$23.34B
Dividend Yield	1.70%	1.71%	2.67%	4.05%
P/E Ratio	17.17	24.87	24.21	31.33
Price / Sales	0.44	17.49	512.05	100.15
Price / Cash	10.75	13.73	27.48	18.65
Price / Book	2.04	5.53	10.66	4.69
Net Income	$5.66B	$179.69M	$3.57B	$1.08B
7 Day Performance	-2.92%	0.62%	0.84%	2.11%
1 Month Performance	1.75%	7.68%	-0.34%	1.95%
1 Year Performance	5.01%	5.88%	25.40%	24.11%

Elevance Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ELV Elevance Health	4.3165 of 5 stars	$403.74 +1.1%	$416.11 +3.1%	+5.0%	$87.75B	$199.13B	17.17	97,100	News Coverage Positive News
CNC Centene	3.4193 of 5 stars	$61.97 +4.0%	$58.94 -4.9%	+18.1%	$30.60B	$194.78B	N/A	61,100	Analyst Forecast
MOH Molina Healthcare	3.1668 of 5 stars	$182.82 +5.3%	$178.53 -2.3%	-32.8%	$9.52B	$45.43B	54.09	19,000	News Coverage Positive News
UNH UnitedHealth Group	4.1759 of 5 stars	$380.03 -0.1%	$399.50 +5.1%	+30.3%	$345.12B	$447.57B	28.70	390,000	Trending News Analyst Forecast Options Volume Analyst Revision
CI Cigna Group	4.8908 of 5 stars	$274.14 -1.2%	$339.50 +23.8%	-6.1%	$72.52B	$274.90B	11.62	67,700	News Coverage Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ELV) was last updated on 6/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Elevance Health (ELV) Competitors

ELV vs. CNC, MOH, UNH, CI, and HUM

How does Elevance Health compare to Centene?

Summary

How does Elevance Health compare to Molina Healthcare?

Summary

How does Elevance Health compare to UnitedHealth Group?

Summary

How does Elevance Health compare to Cigna Group?

Summary

How does Elevance Health compare to Humana?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ELV vs. The Competition

Elevance Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Elevance Health (ELV) Competitors

ELV vs. CNC, MOH, UNH, CI, and HUM

How does Elevance Health compare to Centene?

Which has stronger valuation & earnings, ELV or CNC?

Is ELV or CNC more profitable?

Do analysts recommend ELV or CNC?

Do insiders and institutionals have more ownership in ELV or CNC?

Which has more risk and volatility, ELV or CNC?

Does the media refer more to ELV or CNC?

Summary

How does Elevance Health compare to Molina Healthcare?

Does the media favor ELV or MOH?

Do insiders and institutionals believe in ELV or MOH?

Which has stronger valuation and earnings, ELV or MOH?

Is ELV or MOH more profitable?

Which has more volatility & risk, ELV or MOH?

Do analysts prefer ELV or MOH?

Summary

How does Elevance Health compare to UnitedHealth Group?

Is ELV or UNH more profitable?

Which has more volatility & risk, ELV or UNH?

Do insiders & institutionals believe in ELV or UNH?

Do analysts rate ELV or UNH?

Is ELV or UNH a better dividend stock?

Which has preferable valuation and earnings, ELV or UNH?

Does the media favor ELV or UNH?

Summary

How does Elevance Health compare to Cigna Group?

Is ELV or CI a better dividend stock?

Which has better valuation & earnings, ELV or CI?

Does the media prefer ELV or CI?

Is ELV or CI more profitable?

Which has more volatility & risk, ELV or CI?

Do analysts prefer ELV or CI?

Do institutionals & insiders have more ownership in ELV or CI?

Summary

How does Elevance Health compare to Humana?

Which has more risk & volatility, HUM or ELV?

Does the media favor HUM or ELV?

Do institutionals & insiders have more ownership in HUM or ELV?

Is HUM or ELV more profitable?

Is HUM or ELV a better dividend stock?

Do analysts prefer HUM or ELV?

Which has higher valuation and earnings, HUM or ELV?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ELV vs. The Competition

Elevance Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools